Fetal genes can increase the risk of illness during pregnancy

September 1, 2017 by Steinar Brandslet, Norwegian University of Science and Technology
High magnification micrograph of hypertrophic decidual vasculopathy, as seen in pregnancy-induced hypertension. Credit: Wikipedia

A mother's risk of preeclampsia, a potentially life-threatening illness associated with pregnancy, can be linked in some cases to genes from her fetus. For the first time, a relationship has been found between fetal genes and the risk of preeclampsia in the mother. An international research collaborative has presented this finding in Nature Genetics, first published online earlier this summer.

Preeclampsia affects around 3 percent of births in Norway; worldwide, that number is estimated to be about 5 percent. In the vast majority of cases, the mother has mild symptoms, typically . Nevertheless, is one of the leading causes of death in both and babies around the time of birth, and sometimes the only way to treat it is to deliver the baby, even prematurely.

Little studied

"For the first time ever, we have discovered a fetal gene that increases the risk of preeclampsia," says Ann-Charlotte Iversen at the Department of Clinical and Molecular Medicine at NTNU. She says there has not been much research on the role of fetal genes in triggering the illness.

Preeclampsia usually begins with a problem in the placenta, which is mainly composed of fetal cells. For that reason, it makes sense that fetal cells might have a hand in causing the illness, Iversen said, even though it is the mother's symptoms during the last part of the pregnancy that lead to the diagnosis.

The largest of its kind in the world

"Our findings are particularly solid for three reasons: We analysed a large number of individuals, we found several genetic variables that all point to the same gene associated with the risk, and two independent population studies confirmed that this gene is associated with the risk," Iversen said.

There are also a number of major studies that support the conclusions. CEMIR is one of 12 partners from six countries in an EU project called InterPregGen, which was created in 2011. "We are all working together to uncover the for preeclampsia in the mother and fetus. We have linked a number of major European population studies to conduct the world's largest genetic study of preeclampsia," says Iversen. "Our contribution to the project has been information on a group of women from the HUNT study who have had problematic and healthy pregnancies, as well as information from the Preeclampsia Biobank, which has been collected independently."

The Nature Genetics article includes analyses of material from the Preeclampsia Biobank, including blood samples and tissue samples from placentas that have been collected at St. Olavs and Haukeland University Hospitals. The genetic variants identified by the researchers are associated with the FLT-1 gene, which encodes a protein that, in soluble form, is known as a biomarker for preeclampsia.

The protein contributes to damaging the mother's vascular system causing symptoms such as high blood pressure and an increased amount of protein in the urine. This happens as a result of problems with the placenta, essentially because fetal cells in the placenta produce the protein.

"We have shown here that the risk of disease may be because changes in the gene affect how the protein works and how it affects the mother. This is a fetal gene that gives the mother an increased risk of developing preeclampsia. This find clearly brings us closer to a better understanding of preeclampsia," Iversen said.

"The EU project has brought together geneticists, statisticians and clinicians. NTNU and CEMIR's expertise has been a complementary strength," says Iversen. Gabriela Silva, a PhD candidate, analysed the protein expression of FLT-1 in placental samples from sick and healthy pregnant women, while postdoctoral physician Liv Cecilie Vestrheim Thomsen was central in collecting the placentas.

"We have compared the result with the occurrence of the associated with the risk. This means that we have conducted a functional follow-up of the gene discovery, which has now been published," Iversen says.

Predicting which women will get sick

"CEMIR's Research Group for inflammation in pregnancy has a goal to figure out which disease mechanisms cause problems with the placenta and lead to the development of preeclampsia," says Iversen. The group is working to understand what goes wrong so they can detect problems early in a pregnancy. The goal is to predict which women will develop the disease.

"Our molecular analyses have identified specialized fetal cells in the placenta as the main actors in preeclampsia. These are the same fetal cells that have been identified with this new genetic discovery. This reinforces our conviction that play an active role, and represents a big change in thinking, since research has previously focused most on the mother's immune system. If we want to prevent preeclampsia, we have to understand the foundation for the disease," says Iversen.

Explore further: Altered immune cells may both contribute to preeclampsia and offer new hope for treatment

More information: Ralph McGinnis et al, Variants in the fetal genome near FLT1 are associated with risk of preeclampsia, Nature Genetics (2017). DOI: 10.1038/ng.3895

Related Stories

Altered immune cells may both contribute to preeclampsia and offer new hope for treatment

April 24, 2017
Though the exact cascade of events leading to preeclampsia is unknown, reduced blood flow to the placenta (placental ischemia) is commonly thought to be a factor that contributes to the development of the pregnancy-related ...

Study provides insights on preeclampsia

July 20, 2017
Researchers have developed a method that could help rapidly diagnose preeclampsia in pregnant women. They have also uncovered clues that might help explain why women with preeclampsia often develop an abnormal amount of protein ...

Reflux tablet could save 60,000 lives lost to preeclampsia

January 24, 2017
An international collaboration led by the Translational Obstetrics Group (TOG) based at Mercy Hospital for Women has discovered a treatment that could save many of the 60,000 lives lost each year to preeclampsia.

Stroke risk factors for pregnant women with preeclampsia uncovered

May 25, 2017
Women with preeclampsia, a common complication of pregnancy, face a heightened risk of stroke during pregnancy and postpartum if they have urinary tract infections, chronic high blood pressure, or clotting or bleeding disorders, ...

Lack of a hormone in pregnant mice linked to preeclampsia

June 30, 2017
(Medical Xpress)—A team of researchers from Singapore, the Netherlands and Turkey has isolated a hormone in pregnant mice that appears to be associated with preeclampsia—a pregnancy-related condition characterized by ...

Could trophoblasts be the immune cells of pregnancy?

December 18, 2014
Trophoblasts, cells that form an outer layer around a fertilized egg and develop into the major part of the placenta, have now been shown to respond to inflammatory danger signals, researchers from Norwegian University of ...

Recommended for you

Discovery of the 'pioneer' that opens the genome

January 23, 2018
Our genome contains all the information necessary to form a complete human being. This information, encoded in the genome's DNA, stretches over one to two metres long but still manages to squeeze into a cell about 100 times ...

Researchers identify gene responsible for mesenchymal stem cells' stem-ness'

January 22, 2018
Many doctors, researchers and patients are eager to take advantage of the promise of stem cell therapies to heal damaged tissues and replace dysfunctional cells. Hundreds of ongoing clinical trials are currently delivering ...

Genes contribute to biological motion perception and its covariation with autistic traits

January 22, 2018
Humans can readily perceive and recognize the movements of a living creature, based solely on a few point-lights tracking the motion of the major joints. Such exquisite sensitivity to biological motion (BM) signals is essential ...

Peers' genes may help friends stay in school, new study finds

January 18, 2018
While there's scientific evidence to suggest that your genes have something to do with how far you'll go in school, new research by a team from Stanford and elsewhere says the DNA of your classmates also plays a role.

Two new breast cancer genes emerge from Lynch syndrome gene study

January 18, 2018
Researchers at Columbia University Irving Medical Center and NewYork-Presbyterian have identified two new breast cancer genes. Having one of the genes—MSH6 and PMS2—approximately doubles a woman's risk of developing breast ...

A centuries-old math equation used to solve a modern-day genetics challenge

January 18, 2018
Researchers developed a new mathematical tool to validate and improve methods used by medical professionals to interpret results from clinical genetic tests. The work was published this month in Genetics in Medicine.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.